<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01237171</url>
  </required_header>
  <id_info>
    <org_study_id>Cs131-Lung001</org_study_id>
    <nct_id>NCT01237171</nct_id>
  </id_info>
  <brief_title>A Study of Cesium-131 Brachytherapy Following Sub-Lobar Resection for Early Stage Non Small Cell Lung Cancer</brief_title>
  <official_title>Outcome Study of Cesium-131 Brachytherapy Following Sub-Lobar Resection for Early Stage NSCLC</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IsoRay Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IsoRay Medical, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      For patients diagnosed with early (Stage I) non-small cell lung cancer, a lobe of lung is
      usually removed at surgery to treat the cancer. For some patients, the removal of a lobe of
      lung may leave too little lung behind for easy breathing. For some of these patients, it may
      be possible to perform a smaller-scale surgery (&quot;sub-lobar resection&quot;) and place a
      radioactive implant behind to prevent the cancer from growing back. This study will see how
      these patients do in terms of controlling their disease treated with a radioactive implant
      called Cesium-131.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2010</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Local Recurrence</measure>
    <time_frame>3 Years</time_frame>
    <description>Cancer regrowth in the area where it was surgically removed</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>2 years</time_frame>
    <description>Using questionnaires, data will be collected related to the sense of well-being experienced by the patient after treatment.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>NSCLC</condition>
  <condition>Non Small Cell Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Sub-lobar resection with Cesium-131</arm_group_label>
    <description>All enrolled patients will undergo sub-lobar resection and brachytherapy implant with Cesium-131 in an effort to study and quantify recurrence/control patterns.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Cesium-131 Brachytherapy Seed</intervention_name>
    <description>85 Gray Dose</description>
    <arm_group_label>Sub-lobar resection with Cesium-131</arm_group_label>
    <other_name>Sealed Brachytherapy Source CS-1 (IsoRay Medical)</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with clinical stage I non-small cell lung cancer who are not candidates for full
        lobectomy.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients must have suspicious lung nodule for clinical stage I/recurrent non-small
             cell Lung Cancer

          2. Mass Tumor size &lt; 7 cm

          3. Patient must have a CT scan of the chest with upper abdomen within 90 days prior to
             date of pre-registration.

          4. Patient must have ECOG/Zubrod performance status 0,1, or 2.

        Exclusion Criteria:

          1. Patient has already received high dose radiation to the area

          2. Cancerous nodule is very close to the esophagus or spinal cord, thereby increasing the
             risk of radiation treatment

          3. Pregnancy or unwillingness to practice a form of birth control (i.e. abstinence, oral
             contraceptives, etc.)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bhupesh Parashar, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Weill Medical College of Cornell University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Weill Cornell Medical College</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bhupesh Parashar, M.D.</last_name>
      <phone>212-746-3612</phone>
      <email>bup9001@cornell.edu</email>
    </contact>
    <contact_backup>
      <last_name>Mei-Ki Chan, M.A.</last_name>
      <phone>212-746-9297</phone>
      <email>mbc2004@cornell.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Bhupesh Parashar, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 5, 2010</study_first_submitted>
  <study_first_submitted_qc>November 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 9, 2010</study_first_posted>
  <last_update_submitted>November 8, 2010</last_update_submitted>
  <last_update_submitted_qc>November 8, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 9, 2010</last_update_posted>
  <responsible_party>
    <name_title>Bhupesh Parashar, M.D.</name_title>
    <organization>Weill Corness Medical College</organization>
  </responsible_party>
  <keyword>Brachytherapy</keyword>
  <keyword>Lung Brachytherapy</keyword>
  <keyword>NSCLC</keyword>
  <keyword>Sub-lobar resection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

